Quality - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Essential information about quality assurance and quality control, including analytical methods, analytical method development, statistical methods, and process analytical technology (PAT).

Hospira Recalls Certain Lots of Intravenous Products

October 15, 2014

Hospira voluntary recalls certain lots of several LifeCare products due to potential for leakage.

EMA Releases Pharmacovigilance Meeting Highlights

October 10, 2014

The European Medicines Agency releases highlights from its Pharmacovigilance Risk Assessment Committee safety review meeting in October.

Automation: A Cure-All?

October 2, 2014

Pharmaceutical Technology

Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses the benefits of automated processes.

Pharma Outsourcing Driving Need for Cloud-Based Services

September 29, 2014

PTSM: Pharmaceutical Technology Sourcing and Management

Multidirectional collaboration is critical for the new pharma business model; cloud-based information services can offer a communications alternative.

FDA Releases REMS Report

September 25, 2014

FDA report details risk mitigation projects.

Investigational Product Expiry Management

September 12, 2014

Kurt Lumsden, Director, eCDS Client Services at PAREXEL Informatics, discusses the use of interactive response technologies in investigational product expiry management.

Healthcare Reform in China

September 2, 2014

Chinese healthcare reforms may be a double-edged sword for foreign companies.

The Relevance of Industry Technical Associations

September 2, 2014

Pharmaceutical Technology

Industry associations play a strong role in helping the pharmaceutical industry meet challenges.

Need for Supply Chain Transparency is Acute

September 1, 2014

Pharmaceutical Technology

Biopharma manufacturers must reduce risk in their complex supply chains and establish effective monitoring and control systems.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here